Möchten Sie immer auf dem neuesten Stand bleiben?

Newly appointed head of R&D, Dr. Nirula, joins Recludix from Eli Lilly with over two decades of clinical development experience SAB member, Dr. Ray, has over two decades of experience in...

Fort Collins, Colorado, April 23, 2024 (GLOBE NEWSWIRE) -- The growing prevalence of breast cancer drives the need for diagnostics in the forecast period. The prevalence of breast cancer...

Selbyville, Delaware, April 23, 2024 (GLOBE NEWSWIRE) -- Sleep Medications Market Size is projected to reach USD 38.7 billion by the end of 2032. The growing advances in pharmaceutical R&D...

  L’étude de phase III LUNA 3 du rilzabrutinib pour le traitement de la thrombocytopénie immune a atteint son critère d’évaluation primaire Des données pivots de la première étude de phase III...

Rilzabrutinib LUNA 3 phase 3 study met primary endpoint in immune thrombocytopenia Pivotal data from the first phase 3 study of a BTKi in immune thrombocytopenia (ITP) underscore the potential...

Oral presentations include updated results from clinical study of otoferlin gene therapy DB-OTO demonstrating restoration in children with profound genetic hearing loss Additional presentations...

Ottawa, April 22, 2024 (GLOBE NEWSWIRE) -- The global antacids market size was valued at USD 7.20 billion in 2023 and is predicted to surpass around USD 9.29 billion by 2031, a study published by...

New York, United States, April 22, 2024 (GLOBE NEWSWIRE) -- Probiotics are microorganisms consumed to enhance the function of the digestive system. These microorganisms, also known as beneficial or...

Newark, April 22, 2024 (GLOBE NEWSWIRE) -- The Brainy Insights estimates that the USD 163.2 billion loratadine market will reach USD 221.4 billion by 2033. Loratadine is an antihistamine drug. All...

Dublin, April 22, 2024 (GLOBE NEWSWIRE) -- The "COVID-19 Vaccines - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.Global COVID-19 Vaccines Market to...